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Overnutrition is associated with chronic inflamma-
tion in metabolic tissues. Whether metabolic inflam-
mation compromises the neural regulatory systems
and therefore promotes overnutrition-associated
diseases remains unexplored. Here we show that
a mediator of metabolic inflammation, IKKb/NF-kB,
normally remains inactive although enriched in hypo-
thalamic neurons. Overnutrition atypically activates
hypothalamic IKKb/NF-kB at least in part through el-
evated endoplasmic reticulum stress in the hypothal-
amus. While forced activation of hypothalamic IKKb/
NF-kB interrupts central insulin/leptin signaling and
actions, site- or cell-specific suppression of IKKb
either broadly across the brain or locally within
the mediobasal hypothalamus, or specifically in hy-
pothalamic AGRP neurons significantly protects
against obesity and glucose intolerance. The molec-
ular mechanisms involved include regulation by
IKKb/NF-kB of SOCS3, a core inhibitor of insulin
and leptin signaling. Our results show that the hypo-
thalamic IKKb/NF-kB program is a general neural
mechanism for energy imbalance underlying obesity
and suggest that suppressing hypothalamic IKKb/
NF-kB may represent a strategy to combat obesity
and related diseases.
INTRODUCTION
The hypothalamus is the ‘‘headquarters’’ for regulating energy
homeostasis (Elmquist and Flier, 2004; Schwartz and Porte,
2005). This regulation is primarily mediated in the mediobasal hy-
pothalamus (MBH) by orexigenic AGRP neurons that coexpress
two neuropeptides—NPY (neuropeptide Y) and AGRP (agouti-
related protein)—and anorexigenic POMC neurons that
coexpress two other neuropeptides—CART (cocaine- and am-phetamine-regulated transcript) and POMC (proopiomelanocor-
tin). Leptin and insulin work in these neurons to control these
neuropeptides, leading to normal energy balance and the pre-
vention of obesity. Research has revealed that insulin signaling
and leptin signaling in the hypothalamus are integrated through
at least PI-3K (Morton et al., 2005; Xu et al., 2005), FoxO1 (Kim
et al., 2006; Kitamura et al., 2006), and mTOR (Cota et al.,
2006). Recent studies have also identified two common inhibi-
tors for insulin and leptin signaling, SOCS3 (Howard and Flier,
2006) and PTP1B (Bence et al., 2006), but their significance in
causing disease is poorly understood.
Loss of leptin or insulin signaling in the hypothalamus is suf-
ficient to induce or promote obesity and type 2 diabetes (T2D),
as clearly demonstrated in various genetic mouse models with
neuronal ablation of insulin signaling (Bruning et al., 2000; Burks
et al., 2000; Obici et al., 2002) or leptin signaling (Balthasar
et al., 2004; Bates et al., 2003; Lee et al., 1996). In obesity and
T2D, along with striking hyperinsulinemia and hyperleptinemia,
insulin and leptin levels in the cerebrospinal fluid are elevated,
all of which indicate a chronic state of central insulin and leptin
resistance. Central administration of insulin or leptin consis-
tently compromises the ability to control food intake in animals
during the development of dietary obesity, confirming that
hypothalamic (or central) leptin and insulin resistance contrib-
ute to the pathophysiology of obesity and T2D. Recent
research has also dissociated overnutrition from obesity, dem-
onstrating that overnutrition directly blunts central insulin and
leptin sensitivity before the onset of obesity (Wang et al.,
2001; Woods et al., 2004). However, how central insulin and
leptin resistance are induced by overnutrition and whether
core mechanism(s) might be involved are both currently un-
known.
IKKb/NF-kB is a master switch and central regulator of innate
immunity and related functions (Hayden and Ghosh, 2008). In the
quiescent state, NF-kB remains inactive in the cytoplasm
through binding to the inhibitory protein IkB. Activation of IKKb
by phosphorylation at S177 and S181 induces phosphorylation
of its substrate IkBa at S32 and S36, ubiqitination, and subse-
quent proteosomal degradation. The disappearance of IkBa re-
leases NF-kB to translocate into the nucleus where it mediatesCell 135, 61–73, October 3, 2008 ª2008 Elsevier Inc. 61
the transcription of its target genes. Research during recent
decades recognized that overnutrition can induce inflammatory
responses in the peripheral metabolic tissues (metabolic in-
flammation) and therefore cause various metabolic defects in
those tissues that underlie T2D (Hotamisligil, 2006; Lehrke
and Lazar, 2004). In this context, IKKb was identified as a target
for an anti-inflammatory therapy that was effective for obesity-
associated T2D (Yuan et al., 2001). Subsequently, a series of
discoveries revealed that IKKb/NF-kB located in peripheral
metabolic tissues affects glucose and protein metabolism in
tissue-specific manners (Arkan et al., 2005; Cai et al., 2004,
2005). However, it still remains unexplored whether metabolic
inflammation and related mediators could target the metabolic
regulatory pathways in the central nervous system (CNS), thus
leading to a family of diseases related to overnutrition and obe-
Figure 1. IKKb/NF-kB in the Hypothalamus
and Its Relationship with Overnutrition
(A) Protein levels of IKKb, IKKa, and IkBa in the
hypothalamus (H) versus the peripheral organs in-
cluding liver (L), skeletal muscle (M), fat (F), and
kidney (K) from normal chow-fed C57BL/6 mice.
Tub: tubulin.
(B and C) Distribution of IKKbmRNA and protein in
the hypothalamus was respectively profiled by
probing the brain sections with antisense IKKb
oligonucleotides (B) and by coimmunostaining of
IKKb with NeuN or GFAP (C). The labeled sense
sequence of IKKb oligonucleotides was used as
the control probe (B, right). Bar = 50 mm.
(D) DNA-binding activity of NF-kB and an irrelevant
control (Sp1) was measured using EMSA in the hy-
pothalamus from HFD- versus chow-fed C57BL/6
mice. Cold competition (C) with 200-fold excess of
unlabeled NF-kB oligo and mutant NF-kB probe
(M) was used to assess the specificity of the
NF-kB EMSA blots. N: nonspecific protein (BSA).
(E and F) NF-kB-induced luciferase activity was
measured in the hypothalamus harvested from
the NF-kB reporter mice that received intra-third
ventricle infusion of 6 mg glucose (E) or 40 mg
oleic acid (F) over 6 hr. The controls (Con) repre-
sent the infusion of the empty vehicle or the
same concentrations of sorbitol (n = 4–5 per
group, *p < 0.05). 3V: third ventricle. Error bars
reflect mean ± SEM.
sity. In this study, we explored whether
IKKb/NF-kB is the fundamental connec-
tion between overnutrition and the dys-
functions of hypothalamic signaling that
cause obesity and associated problems.
RESULTS
IKKb/NF-kB Is Enriched but
Suppressed in the Hypothalamus
Obesity and associated diseases are
characterized by a chronic state of meta-
bolic inflammation. We investigated a
possible connection between IKKb/NF-kB and the central dys-
regulation of energy balance in the hypothalamus. First, we dis-
sected the hypothalamus (Figure S1A available online) and the
peripheral organs in normal mice and observed that the IKKb
protein was highly enriched in the hypothalamus (Figure 1A).
For comparison, IKKa, an IKK isoform that has different signaling
and functions from the IKKb/NF-kB axis, is present at similar
levels in the hypothalamus and many of the peripheral tissues
(Figure 1A). Using in situ hybridization, we revealed that IKKb is
expressed predominantly in the MBH (Figure 1B). After confirm-
ing the specificity of IKKb immunostaining (Figures S2 and S3),
we revealed that IKKb is stained in the neurons but is barely
stained in nonneuronal cells (such as astrocytes) in the MBH
(Figure 1C). Thus, IKKb possesses a unique, distinct pattern in
the hypothalamus.62 Cell 135, 61–73, October 3, 2008 ª2008 Elsevier Inc.
When IKKb is inactive, its substrate IkBa remains intact,
which specifically binds to and inhibits NF-kB. We noted that
the levels of IkBa were normally high in the hypothalamus
relative to the levels in the peripheral tissues (Figure 1A), indi-
cating that both IKKb and NF-kB are suppressed in the hypo-
thalamus in normal physiology with standard nutrition. EMSA
further indicated that hypothalamic NF-kB activity was
relatively low in normal mice fed standard chow (Figure 1D).
The super-shift results confirmed that hypothalamic NF-kB is
the canonical complex composed of p65 (RelA) and p50
(Figure S4A). We also employed NF-kB reporter mice (Everhart
et al., 2006), which report NF-kB activity through the NF-kB-
controlled expression of an eGFP-Luciferase fusion protein
(NGL mice). We confirmed that hypothalamic NF-kB activity
was normally modest by measuring either luciferase activity
(Figure S5A) or eGFP expression (Figure S5B) in the hypothal-
amus. In sum, IKKb/NF-kB remains suppressed although
enriched in the hypothalamus under conditions where nutrition
is normal.
Hypothalamic IKKb/NF-kB Is Activated by Overnutrition
We then explored whether IKKb/NF-kB in the hypothalamus
might be affected by overnutrition, a condition that causes obe-
sity and metabolic inflammation. We observed that a chronic
high-fat diet (HFD) feeding upactivated NF-kB in the hypothala-
mus by 2-fold (Figure 1D). NF-kB activity was 5- to 6-fold
higher in the hypothalamus of ob+/+ mice (a hyperphagic obe-
sity), even when fed normal chow, than in the controls (WT
mice) (Figure S4B). We then used the NGL mice to examine
the MBH, the predominant region that expresses IKKb. In con-
trast to the low levels of eGFP expression when the NGL mice
were fed a normal chow, a HFD clearly induced eGFP expression
in the MBH neurons of the NGL mice (Figures S5B and S5C).
Thus, the MBH, the first-order brain region for nutrition sensing,
represents an important hypothalamic site for the activation of
NF-kB through overnutrition. In addition, we observed that
mRNA levels of IKKb and IkBa in the hypothalamus increased
both in C57BL/6 mice fed a HFD and in ob+/+ mice fed a normal
chow (Figure S6). These observations further support our under-
standing that IKKb/NF-kB is upactivated in the hypothalamus by
chronic overnutrition.
We then explored whether the effect of overnutrition on hypo-
thalamic IKKb/NF-kB could be dissected from obesity. NGL
mice fasted overnight received a 6 hr infusion of 20% glucose
at the rate of 5 ml/hr through cannula implanted in the third ven-
tricle. The glucose infusion increased the hypothalamic glucose
content, which reached 80% of the levels seen in obese and di-
abetic db/db mice (Figure S7). Through measuring NF-kB-driven
luciferase activities, we found that the acute overload of glucose
significantly increased the NF-kB activity in the hypothalamus
(Figure 1E) but not in the peripheral tissues. We also performed
an intra-third ventricle infusion of another nutrient species, oleic
acid (OA), using the method and doses established in the recent
literature (Lam et al., 2005). OA infusion increased the hypotha-
lamic NF-kB activity in the NF-kB reporter mice (Figure 1F) in
much the same way as did the glucose infusion. These experi-
ments and results indicate that oversupply of general nutrients
can acutely activate hypothalamic IKKb/NF-kB before the onsetof obesity. On the other hand, we noted that a physiological sup-
ply of nutrients, such as refeeding following a period of fasting,
did not evidently affect hypothalamic NF-kB activity, suggesting
that activation of IKKb/NF-kB is not physiologically required. Our
results suggest that chronic overnutrition most likely provides re-
petitive and persistent signals that upregulate IKKb/NF-kB in the
hypothalamus.
We then determined whether inflammatory molecules, like
those driven by NF-kB typically in immune cells, might be over-
produced in the hypothalamus of obese mice. Quantitative
RT-PCR revealed normal mRNA levels in the hypothalamus of
either HFD-fed C57BL/6 mice or normal chow-fed ob+/+ mice
for almost all the cytokines and their receptors that we examined
(Table S1). In contrast, quantitative RT-PCR revealed markedly
elevated mRNA levels in the NF-kB signaling components, in-
cluding IKKb and IkBa, in the hypothalamus (Figure S6). Consis-
tent with recent literature (Munzberg and Myers, 2005), SOCS3
mRNA levels in the hypothalamus of HFD-treated mice and nor-
mal chow-fed ob+/+ mice were both moderately increased. We
therefore suggest that the neuronal activation of IKKb/NF-kB
in the hypothalamus by overnutrition leads to neuron-specific
responses mostly associated with noncytokine program(s).
Targeting IKKb/NF-kB in the Hypothalamus
and in the Brain to Control Obesity
We previously reported that constitutively active IKKb (IKKbCA)
mimics IKKb phosphorylation, leading to chronic activation of
NF-kB (Cai et al., 2004, 2005). Here, we first cloned IKKbCA
into a lentiviral vector, in which the synapsin promoter controls
the neuron-specific expression of Flag-tagged IKKbCA. In paral-
lel, we also cloned dominant-negative (inhibitory) IKKb (IKKbDN)
into the same viral vector. The same lentiviral vector containing
GFP was used as the control. Using the technique of MBH-
directed injections (Figures S1B, and S1C), we delivered each
lentivirus bilaterally into the MBH of HFD-fed C57BL/6 mice.
While no anatomic lesions were caused, site-specific expression
of the targets was confirmed by immunostaining of IKKb-conju-
gated Flag tag (Figure 2A). With low-level but persistent exoge-
nous activation of IKKb/NF-kB in the MBH by expressed IKKbCA,
HFD intake and weight gain of the mice were significantly
although mildly promoted (Figures 2B and 2C). Conversely, deliv-
ery of IKKbDN in the MBH neurons reduced the levels of HFD-in-
duced weight gain by restricting HFD intake (Figures 2B and 2C).
Considering the disadvantages of a viral approach, such as
random infections and immunogenicity of viral particles, we fur-
ther employed mouse models with genetic suppression of IKKb
in the brain. We first crossed IKKblox/lox mice (Arkan et al., 2005)
with a line of brain-specific Cre transgenic mice, Nestin-Cre
mice; both lines had the C57BL/6 background. The compound
offspring, Nestin/IKKblox/lox mice, contained brain-specific
ablation of IKKb (Figure 2D). Compared with the two types of
littermate controls, Nestin-Cre mice and IKKblox/lox mice, the
Nestin/IKKblox/lox mice demonstrated normal development,
growth, body weight, and food intake when fed a chow. When
fed a HFD, the Nestin/IKKblox/lox mice were significantly pro-
tected from the induction of obesity (Figure 2E). In contrast, nei-
ther of the two control groups (Figures 2E and S8A) displayed
any significant protection. Compared to the control mice, theCell 135, 61–73, October 3, 2008 ª2008 Elsevier Inc. 63
Nestin/IKKblox/lox mice consumed a reduced but healthy amount
of HFD (Figures 2F and S8B), which mainly accounted for the an-
tiobesity manifestation in the knockout mice.
To further narrow our focus to the hypothalamus, we com-
bined the genetic model with recombinant adenoviruses to se-
lectively ablate IKKb in the MBH. By delivering Cre-expressing
recombinant viruses into the MBH of IKKblox/lox mice, the floxed
IKKb was excised by Cre expression in the infected MBH cells of
IKKblox/lox mice (MBH-Cre/IKKblox/lox mice). For the controls,
we injected GFP-expressing adenoviruses into the MBH of
IKKblox/lox mice (MBH-GFP/IKKblox/lox mice). Before the injec-
tions, we provided a HFD to both groups of IKKblox/lox mice for 1
month to initiate dietary obesity, and following the injections, we
continued to treat both mouse groups with the HFD. Using this
protocol, we observed that the HFD increased body weight to a
much lesser degree in the MBH-Cre/IKKblox/lox mice than in the
control mice (Figure 2G). Consistently, the MBH-IKKblox/lox mice
consumed less HFD than did the controls (Figure 2H). These re-
Figure 2. Mouse Phenotypes with Brain
or Hypothalamic IKKb Manipulations
(A) Immunostaining using anti-Flag antibody for
the hypothalamic sections from mice that received
intra-MBH injections of Flag-IKKbCA lentivirus and
the control lentivirus. Bar = 50 mm.
(B and C) HFD-fed C57BL/6 mice received intra-
MBH injections of a lentivirus in which the synap-
sin (Syn, S) promoter was employed to direct the
neuronal expression of IKKbCA, IKKbDN, and con-
trol GFP. Weight gain (B) and food intake (C)
were followed after the mice recovered from injec-
tions and surgeries (n = 4–6 per group, *p < 0.05).
(D) Immunostaining of IKKb in the hypothalamus of
Nestin/IKKblox/lox mice versus the control IKKblox/lox
mice. Lower panels: the IKKb staining (green) was
merged with the nuclear staining of the MBH cells
(blue) by DAPI. Bar = 50 mm.
(E and F) Body weight (E) and daily food intake (F)
were measured for HFD-fed Nestin-IKKblox/lox
mice versus littermate IKKblox/lox mice (n = 5–6
per group, *p < 0.05, **p < 0.01).
(G and H) Body weight gain (G) and HFD intake (H)
were measured in IKKblox/lox mice that received
MBH injections of Cre- or GFP-adenovirus (n =
11–13 per group, *p < 0.05, **p < 0.01). Error
bars reflect mean ± SEM (B, C, and E–H).
sults further support that suppression of
IKKb/NF-kB in the MBH offers resistance
to obesityunderconditions ofovernutrition.
The Connection of Hypothalamic
IKKb/NF-kB with Overnutrition
by ER Stress
We then explored the intracellular com-
ponents that could mediate nutritional
activation of IKKb/NF-kB in the hypothal-
amus and subsequently cause diseases.
Recently, ER (endoplasmic reticulum)
stress was identified as a critical intracel-
lular event that induces metabolic diseases under conditions of
overnutrition (Ozcan et al., 2004, 2006). We asked whether ER
stress might be involved in the pathways that mediate nutritional
activation of hypothalamic IKKb/NF-kB, and then disease. We
first found that ER stress in the hypothalamus, quantitated by
the phosphorylation levels of PERK, could be evidently induced
by a HFD (Figure 3A), along with the HFD induction of NF-kB
activation in the hypothalamus (Figure 1D). Furthermore, we re-
vealed that the activation of hypothalamic NF-kB by a HFD
was suppressed by an acute intra-third ventricle infusion of an
ER stress inhibitor, tauroursodeoxycholic acid (TUDCA) (Figures
3A and 3B). In addition, we treated normal chow-fed C57BL/
6 mice by an acute intra-third ventricle administration of an ER
stress inducer, tunicamycin (TM). Our results revealed that TM
activated hypothalamic NF-kB, while it remarkably promoted
ER stress in the hypothalamus (Figures 3C and 3D). Thus, ER
stress is an intracellular mediator of hypothalamic IKKb/NF-kB
activation by overnutrition.64 Cell 135, 61–73, October 3, 2008 ª2008 Elsevier Inc.
We further employed our lentiviral approach and mouse model
to dissect the relationship between ER stress and IKKb/NF-kB in
the hypothalamus. Using intrahypothalamic injections of IKKbCA
lentivirus, we found that activating IKKb/NF-kB elevated ER
stress in the hypothalamus, which was reflected by increased
levels of both PERK and eIF2a phosphorylation (Figure 3E).
This result indicates that ER stress is both an upstream mediator
and a downstream event of IKKb/NF-kB activation in the hypo-
thalamus. This claim was further supported by our findings
demonstrating that HFD failed to induce ER stress in the hypo-
thalamus of the Nestin/IKKblox/lox mice (Figure 3F). Based on
the dual roles of ER stress in the pathological cascade of hypo-
thalamic IKKb/NF-kB, we assessed the potential disease rele-
vance of ER stress in the CNS. To do this, we provided a chronic
intra-third ventricle treatment of TUDCA for mice with obesity
induced by a HFD. We found that while the TUDCA treatment
did not cause obvious side effects, it significantly decreased
the degree of obesity (Figure 3G), which was associated with
the re-balance of food intake in these mice (Figure 3H). The an-
Figure 3. The Association of ER Stress with
IKKb/NF-kB in the Hypothalamus
(A–D) Normal chow (Ch)-fed mice (A–D) and HFD-
fed matched mice (A and B) received intra-third
ventricle infusions of (+) 25 mg TUDCA (B) or 3 mg
TM (C) versus the vehicle control () over 2 hr
(A–D). The markers of ER stress (A and D) and
the DNA-binding activities of NF-kB and an irrele-
vant control (Sp1) (B and C) in the hypothalamus of
these mice were measured using western blot and
EMSA, respectively.
(E and F) The ER stress markers were measured in
the hypothalamus of normal chow-fed mice that
received intra-MBH injections of IKKbCA- versus
GFP-lentivirus (E) and normal chow- versus HFD-
fed Nestin/IKKblox/lox mice (N/IKKbl/l) and their
controls (IKKblox/lox mice, IKKbl/l) (F).
(G and H) HFD-fed mice received daily intra-third
ventricle injections of TUDCA (5 mg/day) or the
empty vehicle (aCSF) for 10 days. The body weight
(G) and average food intake (H) of these mice were
measured before (day 0) and upon the completion
of the 10 day therapy (n = 5 per group, *p < 0.05).
Error bars reflect mean ± SEM.
tiobesity benefits caused by suppressing
ER stress in the CNS resemble the anti-
obesity effects from suppressing IKKb/
NF-kB in the CNS (Figure 2). Thus, under
conditions of overnutrition, ER stress and
IKKb/NF-kB in the hypothalamus enhance
each other, leading to the central mecha-
nisms of energy imbalance and disease.
Activating Hypothalamic
IKKb/NF-kB Causes Central
Insulin and Leptin Resistance
Insulin resistance can be caused in the
peripheral tissues by either activating
IKKb/NF-kB (Cai et al., 2005) or ER stress
(Ozcan et al., 2004, 2006). Since insulin signaling in the hypothal-
amus is also critical for the central regulation of food and weight
balance, we examined whether IKKb/NF-kB interrupts central
insulin signaling in the hypothalamus. We delivered IKKbCA bilat-
erally into the MBH of adult C57BL/6 mice using an adenoviral
vector. As controls, we used the same viral vector in which
IKKbCA was replaced by either GFP or IKKbDN. We observed
that IKKbCA remarkably impaired Akt activation in response to
a third ventricle injection of insulin, but Akt activation was not
affected by either IKKbDN or GFP (Figure 4A). Tyrosine phosphor-
ylation in IR and IRS2 and the binding of IRS2 to PI3 kinase sub-
unit p85 were all suppressed by IKKbCA (Figure S9), although the
effects were somewhat milder. The inhibitory effects of IKKbCA
on insulin signaling were also recapitulated in vitro in hypotha-
lamic GT1-7 cells (Figure S10). These results further reinforce
the negative relationship between IKKb/NF-kB and hypotha-
lamic insulin signaling.
We also employed immunostaining to directly examine the
effects of IKKbCA on insulin signaling in the MBH. After havingCell 135, 61–73, October 3, 2008 ª2008 Elsevier Inc. 65
confirmed the specific immunostaining for insulin-induced PIP3
production in the MBH in overfasted mice (Figure S11), we used
adenovirus to deliver IKKbCA into one side of the MBH and GFP
into the other side of the MBH in the same mice (Figure 4Ca),
which provided the best means of comparison. In response
to a third-ventricle injection of insulin, PIP3 was normally in-
duced in the MBH side with GFP; in contrast, very little PIP3
was induced in the MBH side with IKKbCA (Figure 4Cb), indicat-
ing that IKKbCA caused severe insulin insensitivity in the MBH.
Following these signaling analyses, we continued to evaluate
whether a bilateral delivery of IKKbCA into the MBH was suffi-
cient to affect the ability of central insulin administration to sup-
press food intake. We found that insulin decreased food intake
induced by fasting in the control mice that expressed GFP in
Figure 4. IKKb/NF-kB in the MBH Mediates
Central Insulin and Leptin Resistance
(A and B) An adenovirus was injected to deliver
IKKbCA, IKKbDN, or GFP to both MBH sides of nor-
mal C57BL/6 mice. Following surgical recovery,
24 hr-fasted mice received third-ventricle injec-
tions of either insulin (A) or leptin (B) (+), or the
empty vehicle () (A and B). Proteins in the dis-
sected hypothalamus were immunoblotted with
the indicated antibodies.
(C) Adult C57BL/6 mice were injected with ade-
noviruses to deliver IKKbCA into one side of the
MBH and GFP into the other side (a) of the
same mice. Recovered mice were fasted 48 hr
and then stimulated with insulin (a–b) or leptin
(c–d) for 20 min via third-ventricle cannula. Brain
sections across the MBH were directly examined
for GFP (a) and immunostained with the indi-
cated primary antibodies (b–d). Arrows indicate
the regions in which the injected genes (IKKbCA
and GFP) were expressed. Bar = 100 mm.
(D and E) An adenovirus was injected into adult
C57BL/6 mice to deliver either IKKbCA to both
sides of the MBH of one group of mice or GFP
to both sides of the MBH of another group of
mice. Recovered mice fasted for 4 hr received
third-ventricle injections of insulin (D), leptin (E),
or the vehicle (aCSF) (D and E). Food intake dur-
ing the indicated time periods following the insu-
lin or leptin injections was measured. (Insulin:
n = 12 per group; leptin: n = 7–8 per group; *p <
0.05.) NS = nonsignificant. Error bars reflect
mean ± SEM.
the MBH; in contrast, insulin failed to
significantly decrease food intake in-
duced by fasting in mice that expressed
IKKbCA in the MBH (Figure 4D). Thus,
from a functional standpoint, this result
again suggests that local activation of
IKKb/NF-kB in the MBH impairs hypo-
thalamic insulin signaling.
Recent research has established that
insulin and leptin signaling function
together in the hypothalamus to control
energy balance. We explored whether activation of IKKb/NF-
kB in the MBH might also affect hypothalamic leptin signaling.
We continued to employ the mouse models in which either
IKKbCA or a control was bilaterally delivered into the MBH. Our
western blots (Figure 4B) and immunostaining (Figures 4Cc–
4Cd, S11C, and S11D) both revealed that leptin-induced
STAT3 phosphorylation in the hypothalamus was reduced by
IKKbCA in the MBH. Furthermore, we observed that while leptin
reduced fasting-induced food intake by 50.0% in the
control mice that expressed GFP bilaterally in the MBH, the re-
duction was only 26.5% in mice that expressed IKKbCA
bilaterally in the MBH (Figure 4E). To summarize, IKKb/NF-kB
activation in the MBH causes both central insulin and leptin
resistance.66 Cell 135, 61–73, October 3, 2008 ª2008 Elsevier Inc.
IKKb Ablation in Hypothalamic AGRP Neurons
Controls Obesity
Because IKKb/NF-kB activation interrupts insulin and leptin sig-
naling, we hypothesized that ablating IKKb in the insulin- and
leptin-sensitive hypothalamic neurons might yield relevant met-
abolic effects. We targeted AGRP neurons, which are localized
mainly in the MBH and are a critical source of hypothalamic insu-
lin and leptin signaling. We bred IKKblox/lox mice with AGRP-Cre
mice in which Cre was located almost exclusively in the targeted
MBH neurons (Xu et al., 2005) (Figure S12). Our data verified the
suitability of AGRP-Cre mice for this study by showing that
AGRP-Cre mice, when fed either a chow or a HFD, consumed
food and gained body weight similarly to wild-type mice (Figures
S8C and S8D). We refer to offspring with the AGRP neuron-spe-
cific knockout of IKKb (confirmed in Figure 5A by immunostain-
ing) as AGRP/IKKblox/lox mice. Littermate AGRP-Cre mice and
IKKblox/lox mice were used as controls. As noted previously (Xu
et al., 2005), a fraction of AGRP/IKKblox/lox mice exhibited partial
Figure 5. Antiobesity Effects of Knocking
out IKKb in the Hypothalamic AGRP
Neurons
(A) AGRP (a and c) and IKKb (b and d) in the hypo-
thalamus of the control mice (IKKblox/lox mice)
(a and b) versus AGRP-IKKblox/lox mice (c and d)
were immunostained. Immunostaining of AGRP
(c) and IKKb (d) and the nuclear staining by DAPI
(e) in the hypothalamus of AGRP-IKKblox/lox mice
were merged to display the absence of IKKb in
AGRP neurons (f). Bar = 25 mm.
(B–D) Body weight (BW) (B), accumulated HFD
intake (C), and glucose tolerance (GTT) (D) were
tested in HFD-fed AGRP-IKKblox/lox mice and
IKKblox/lox mice (n = 12–14 per group, *p < 0.05,
**p < 0.01). Glu, Glucose.
(E and F) HFD-fed AGRP-IKKblox/lox mice and
IKKblox/lox mice were fasted and received third-
ventricle injections of insulin (5 mU) (E), leptin
(10 mg) (F), or the vehicle (aCSF) (E and F). Insu-
lin-induced Akt phosphorylation (pAkt) (E) and
leptin-induced STAT3 phosphorylation (pSTAT3)
(F) were determined using western blots.
(G and H) Adenovirus was injected to deliver IKKb
to both MBH sides of AGRP-IKKblox/lox mice. For
the controls, adenovirus was injected to deliver
GFP to both MBH sides of AGRP-IKKblox/lox mice
and to both MBH sides of IKKblox/lox mice. Body
weight (G) and food intake (H) in these mice were
followed for 8 weeks following the viral injections
(n = 5 per group, *p < 0.05, **p < 0.01). Error bars
reflect mean ± SEM (B–D, G, and H). IKKbl/l:
IKKblox/lox mice; A/IKKbl/l: AGRP-IKKblox/lox mice.
IKKb excision in the whole body due to
occasional promoter leakage during the
embryonic development; we identified
these mice using a PCR method and
excluded them from the studies.
AGRP/IKKblox/lox mice displayed
normal offspring frequency, growth, and
activity. When fed normal chow, the body
weight and food intake of these mice
resembled those of the control mice, including AGRP-Cre,
IKKblox/lox, and wild-type mice. Therefore, the AGRP/IKKblox/lox
mice represent a suitable model for studying the hypothalamic
control of energy balance. We treated the AGRP/IKKblox/lox mice
and the matched controls with a HFD post-weaning. After 12
weeks of the HFD, the body weight of AGRP/IKKblox/lox mice was
13.1% less than that of the controls (Figure 5B). On average,
AGRP/IKKblox/lox mice ate 10.2% less than the controls (Fig-
ure 5C). The antiobesity phenotype of the AGRP/IKKblox/lox mice
almost reached the level of the Nestin/IKKblox/lox mice (Figure 2),
thus suggesting that AGRP neurons are mainly responsible for
the neural effects of IKKb/NF-kB on body weight homeostasis.
We also assessed the antiobesity characteristics of the AGRP/
IKKblox/lox mice from the aspects of obesity-associated glucose
intolerance and central insulin/leptin resistance. HFD-fed AGRP/
IKKblox/lox mice and the matched controls were fasted overnight
and subjected to a glucose tolerance test (GTT). As expected,
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3 months of a HFD. In contrast, HFD failed to induce glucose
intolerance in the AGRP/IKKblox/lox mice (Figure 5D). We also
assessed central insulin and leptin resistance as two biochem-
ical markers of obesity. Compared to mice fed a normal chow,
both insulin and leptin signaling were barely induced in the mice
fed a HFD, indicating a state of central insulin and leptin resis-
tance that was chronically induced by HFD. In contrast, both
insulin and leptin signaling were significantly preserved in the
hypothalamus of HFD-fed AGRP/IKKblox/lox mice (Figures 5E
and 5F) in which only the AGRP neurons were targeted for
IKKb ablation.
To further confirm that the metabolic phenotypes of AGRP/
IKKblox/lox mice were hypothalamic, we used an adenovirus to bi-
laterally deliver either IKKb or control GFP into the MBH of
AGRP/IKKblox/lox mice that had been fed a HFD for 2 months.
As further controls, we used the same approach to deliver
IKKb or GFP into the MBH of the littermate IKKblox/lox mice that
were also fed a HFD for 2 months. We observed that the protec-
tion against the induction of weight gain by a HFD in AGRP/
IKKblox/lox mice was eliminated by restoring IKKb in the MBH
(Figure 5G). To reflect such a phenotype reversal, intake of the
HFD in AGRP/IKKblox/lox mice nearly approached the levels dis-
played by IKKblox/lox mice during the progression to obesity (Fig-
ure 5H). In sum, the hypothalamic AGRP neurons are critical for
the pathological action of IKKb/NF-kB in the central dysregula-
tion of energy balance.
IKKb/NF-kB Promotes SOCS3 Expression
Our results led to the consideration of how IKKb/NF-kB causes
hypothalamic insulin and leptin resistance. Recent research
shows that SOCS3 is a critical inhibitor for both insulin and leptin
signaling in the hypothalamus (Howard et al., 2004; Mori et al.,
2004; Ueki et al., 2004). Using luciferase driven by the mouse
SOCS3 promoter in the pGL3 plasmid (SOCS3-pGL3), we tested
whether NF-kB regulates the promoter activity of SOCS3 in cul-
tured cells. This SOCS3 promoter contains two putative NF-kB-
DNA binding motifs at 94 and 754 bp. Our results revealed
that IKKbCA expression increased SOCS3 promoter activity
(Figure S13A). This increase was abolished by expressing the
IkBa super-repressor (IkBaSR) (Figure S13A), which selectively
inhibited NF-kB but not the upstream IKKb. In addition to the
promoter assay, we also found that both mRNA and protein
levels of SOCS3 were stimulated by TNF-a (an activator of
IKKb/NF-kB) in HEK293 cells, and these effects were reversed
by expressing IkBaSR in these cells (Figures S14A and S14B).
All these results indicate that IKKb/NF-kB possesses the ability
to activate the SOCS3 gene.
We then screened various stimuli that increase SOCS3 pro-
moter activity in cultured cells and further tested whether addi-
tion of IkBaSR could inhibit the increase. In HEK293 cells stably
expressing leptin receptor, leptin increased SOCS3 promoter
activity, but interestingly, insulin also increased its activity
(Figure S13B). Further, IkBaSR reduced the effects of leptin
and insulin in stimulating the SOCS3 promoter activity (Fig-
ure S13B). Therefore, SOCS3, classically produced by STAT3
that can be activated through leptin, is also controlled by NF-
kB. To further support this hypothesis, we deleted each of the
two putative NF-kB-DNA binding motifs in the SOCS3-pGL368 Cell 135, 61–73, October 3, 2008 ª2008 Elsevier Inc.plasmid. The activity of the SOCS3 promoter was substantially
reduced by deleting either NF-kB-DNA binding motif
(Figure S13C). These results further suggest that IKKb/NF-kB
is involved in SOCS3 gene activation. In addition, using RT-
PCR and western blot analyses (Figures S14C and S14D), we
confirmed that a virus-mediated delivery of IKKbCA into the
MBH significantly elevated SOCS3 mRNA and protein in the hy-
pothalamus of mice fed a normal chow. The induction of SOCS3
by IKKbCA in the hypothalamus is relatively modest but nonethe-
less correlates with a similar increase of hypothalamic SOCS3
under conditions of overnutrition (Table S1). Further, the modest
increase of SOCS3 is reminiscent of the ‘‘low-grade levels’’ of
metabolic inflammation present in obesity and related diseases
and could be pathogenically relevant to the development of
these diseases.
SOCS3 Mediates the Effects of Hypothalamic
IKKb/NF-kB on Energy Balance
Following our observation showing that a HFD failed to
increase the hypothalamic levels of SOCS3 mRNA in Nesti-
n-IKKblox/lox mice (Figure 6A), we further examined whether
the acute promotion of hypothalamic SOCS3 mRNA by leptin
could be impaired by IKKb ablation. We tested this question us-
ing AGRP-IKKblox/lox mice since we have demonstrated that the
hypothalamic AGRP neurons are mainly responsible for the an-
tiobesity effect created by IKKb ablation. Our results revealed
that hypothalamic SOCS3 mRNA levels in the AGRP-IKKblox/lox
mice were elevated by leptin to lesser degrees than in the control
mice (Figure 6B). These data suggest that SOCS3 might be in-
volved in the hypothalamic IKKb/NF-kB’s dysregulation of en-
ergy balance.
Indeed, after confirming the specificity of SOCS3 immunos-
taining (Figures S15 and S16), we revealed that a HFD signifi-
cantly induced SOCS3 in the MBH (Figure 6C). We also noted
that the induction of SOCS3 in the MBH by overnutrition ap-
peared to be limited to the neurons, which evidently differs
from the massive induction of SOCS3 in many glial cells in re-
sponse to third-ventricle injections of cytokines such as LIF
(Figure S16B). The neuronal activation of SOCS3 by HFD aligns
well with our model showing that IKKb/NF-kB possesses neuro-
nal, noncytokine program(s) for mediating the dysregulation of
energy balance during overnutrition. To further examine the
role of SOCS3 in the pathogenic cascade of hypothalamic
IKKb/NF-kB during overnutrition, we employed a rescue experi-
ment to determine whether adding SOCS3 to the MBH neurons
of AGRP-IKKblox/lox mice could reduce the antiobesity pheno-
type in these mice. We created a SOCS3 lentivirus controlled
by a neuron-specific (synapsin) promoter. For the controls, we
used the same lentivirus but with SOCS3 replaced by GFP. Fol-
lowing the intra-MBH injections of lentiviruses (Figure 6D), the
mice were maintained on a HFD. Our study revealed that the ex-
ogenous expression of SOCS3 in the MBH neurons significantly
decreased the antiobesity and feeding phenotypes of AGRP-
IKKblox/lox mice (Figures 6E and 6F). Therefore, from a mechanis-
tic point, these results further support our hypothesis that
suppressing IKKb/NF-kB in hypothalamic neurons represents
a promising strategy for counteracting obesity and associated
diseases during overnutrition.
DISCUSSION
Overnutrition Subverts the Innate Immune Response
of Hypothalamic IKKb/NF-kB
Obesity and its co-morbidities represent one of the greatest ep-
idemic and public health problems facing our society. Relatively
recent environmental changes, especially overnutrition, are
clearly responsible for the high prevalence of these diseases.
Faced with the energy abundance typical of today’s developed
world, our control systems have yet to evolve to readily regulate
the body’s energy balance. This newly emerged challenge to the
control systems in our bodies has led to excessive energy stores
(fat) and ultimately to disease. While the CNS control systems,
like the hypothalamus, might conceivably be essential for this
regulatory failure, the participating molecular program(s) remain
unknown.
Our work shows that the ‘‘master switch’’ innate immunity reg-
ulator, IKKb/NF-kB, while highly enriched in the hypothalamic
neurons is normally not activated. Importantly, this pathway
Figure 6. The Role of SOCS3 for the Anti-
obesity Phenotype of AGRP-IKKblox/loxMice
(A) Relative mRNA levels of SOCS3 in the hypo-
thalamus of HFD- and chow-fed Nestin-IKKblox/lox
mice and IKKblox/lox mice.
(B) Relative mRNA levels of SOCS3 in the hypo-
thalamus of chow-fed IKKblox/lox mice and AGRP-
IKKblox/lox mice that received third-ventricle
injections of leptin (A and B: n = 4–6 per group,
*p < 0.05, **p < 102, ***p < 103).
(C) SOCS3 immunostaining in the MBH of chow-
versus HFD-fed C57BL/6 mice.
(D) Immunostaining of Cre (green) and SOCS3
(red) in chow-fed AGRP-IKKblox/lox mice following
intra-MBH injections of SOCS3 lentivirus.
(E and F) SOCS3 lentivirus (SOCS3) or GFP lentivi-
rus (GFP) was injected into the MBH of HFD-fed
AGRP-IKKblox/lox mice; body weight (E) and HFD
intake (F) of injected mice were recorded (n =
4–8 per group, *p < 0.05, **p < 0.01). C and D:
Bar = 50 mm. (A–F) IKKbl/l: IKKblox/lox mice; N/
IKKbl/l: Nestin-IKKblox/lox mice; A/IKKbl/l: AGRP-
IKKblox/lox mice. Error bars reflect mean ± SEM.
can be activated in the hypothalamic
neurons by the chronic overnutrition
that causes obesity. Such activation can
even be mimicked without obesity by an
acute but extreme oversupply of various
nutrients to the CNS. Our findings indi-
cate that persistent signals to the CNS
under conditions of overnutrition can
atypically stimulate an innate immunity-
like response directed by IKKb/NF-kB in
the hypothalamic neurons; this process
affects the neuronal regulation of energy
balance (Figure 7). Overall, our findings
align with the emerging view that evolu-
tion integrated some regulatory path-
ways that govern the body’s reactions to both pathogens and
nutrition (Hotamisligil, 2006). We postulate that the hypothala-
mus might have developed the unique property of responding
to extreme environmental stimuli (previously pathogens, now
overnutrition) by using IKKb/NF-kB to affect vital systems.
Thus, although the near-instantaneous signaling of hypotha-
lamic IKKb/NF-kB might once have been critical for survival in
a pathogen-filled environment by helping innate immunity (an en-
ergy-intensive process), this signaling—as our study demon-
strates—might now be very responsive and truly detrimental in
today’s near-constant calorie-rich environment. Hypothalamic
IKKb/NF-kB could underlie the entire family of modern diseases
induced by overnutrition and obesity.
The Hypothalamus as a Key Target for Metabolic
Inflammation via IKKb/NF-kB
Obesity and its associated diseases are characterized by
chronic metabolic inflammation (Hotamisligil, 2006; Lehrke and
Lazar, 2004). This type of inflammation has been consideredCell 135, 61–73, October 3, 2008 ª2008 Elsevier Inc. 69
peripheral and a consequence of obesity. Our previous research
established that IKKb/NF-kB promotes metabolic inflammation
in peripheral tissues (Cai et al., 2004, 2005). In this study, our re-
search originated in an exploration of the potential metabolic rel-
evance of the proinflammatory master switch IKKb/NF-kB in the
hypothalamus. We discovered that IKKb/NF-kB in the hypotha-
lamic neurons responds to the metabolic signals produced by
overnutrition and is a general cause of multiple neural disease
pathways and thus contributes to diseases related to overnutri-
tion. Therefore, while obesity induces metabolic inflammation,
our discovery indicates that metabolic inflammation could also
promote energy imbalance and obesity by interrupting regula-
tory signaling in the CNS. It is also noteworthy that the hypotha-
lamic dysregulation of energy balance by overnutrition involves
a neuron-specific, noncytokine program through IKKb/NF-kB.
This program significantly differs from the inflammatory reac-
tions seen in the CNS of certain chronic, cachectic diseases
(such as cancer, AIDS, and infectious diseases) that are often as-
sociated with chaotic releases and powerful actions of many in-
flammatory cytokines in nonneuronal cells, such as astrocytes,
oligodendrocytes, and microglial cells.
A relevant question therefore concerns how overnutrition acti-
vates IKKb/NF-kB in the hypothalamus. We demonstrated that
Figure 7. Schematic of the Proposed Role of Hypothalamic IKKb/
NF-kB and ER Stress in Obesity-Related Disease Pathways
We propose that IKKb/NF-kB connects with ER stress in the hypothalamus
and translates overnutrition into central insulin and leptin resistance, leading
to the development of obesity and T2D (solid arrows). We also further postulate
that, as obesity and T2D progress, IKKb/NF-kB participates in cumulative
feedback loops (broken arrows).70 Cell 135, 61–73, October 3, 2008 ª2008 Elsevier Inc.an acute, local oversupply of either glucose or lipid in the CNS
recapitulated the hypothalamic activation of IKKb/NF-kB by
chronic overnutrition. This separation of chronic overnutrition
from obesity suggests that overnutrition might at least primarily
activate IKKb/NF-kB in the hypothalamus. The effects of the in-
dividual nutrient species in the hypothalamus agree with many
other studies showing that both glucose and lipid can activate
IKKb/NF-kB in the peripheral metabolic tissues and cultured
cells. A recent report found that Toll-like receptor 4 (TLR4) medi-
ates lipid-induced insulin resistance (Shi et al., 2006). Since TLR4
is an activator of IKKb/NF-kB in various circumstances (Hayden
and Ghosh, 2008), TLR4 could be a link between overnutrition
and IKKb/NF-kB activation at the cell membrane level, but
whether this potential relationship occurs in the hypothalamus
remains to be explored. In this study, we show that ER stress
and IKKb/NF-kB promote each other in the hypothalamus during
overnutrition. This finding indicates that overnutrition could acti-
vate IKKb/NF-kB at the intracellular level in the hypothalamic
neurons. Overall, this profile of hypothalamic IKKb/NF-kB rein-
forces recent research in which ER stress was implicated in met-
abolic inflammation (Hotamisligil, 2006). Furthermore, in addition
to the primary induction of hypothalamic IKKb/NF-kB by en-
riched nutrients, we postulate that the pathophysiological
changes during the progress of obesity and T2D, such as hyper-
lipidemia, hyperglycemia, hyperinsulinemia, hyperleptinemia,
and elevated inflammatory substances in the peripheral tissues
and circulation, might secondarily, but significantly, promote
ER stress and IKKb/NF-kB in the hypothalamus and accelerate
disease progression (Figure 7).
IKKb/NF-kB: A Core Mechanism for Hypothalamic
Insulin and Leptin Resistance
Insulin and leptin signaling in the hypothalamus are critical for
sensing the availability of fuel in the body and preventing exces-
sive energy stores, and thus obesity. Recent research discov-
ered that insulin and leptin signaling are integrated and function
together to regulate energy balance. The PI-3K/Akt, FoxO1,
MAP kinase, and mTOR pathways have recently been identified
as molecular links between insulin and leptin signaling. Recent
research has also demonstrated that overnutrition induces hypo-
thalamic insulin and leptin resistance, but the underlying basis
remains unknown. In this research, we discovered that IKKb/
NF-kB in the hypothalamus mediates both hypothalamic insulin
and leptin resistance. Thus, our findings posit IKKb/NF-kB as
a core disease pathway that mediates hypothalamic insulin
and leptin resistance that leads to obesity and T2D.
Recent research has revealed that SOCS3 is a common inhib-
itor for leptin and insulin signaling (Howard and Flier, 2006).
Indeed, forced overexpression of SOCS3 decreases both lep-
tin-induced phosphorylation of JAK2 and insulin-induced phos-
phorylation of IR, IRS, and Akt. Selectively ablating the SOCS3
gene in hypothalamic neurons can enhance hypothalamic leptin
signaling, which is sufficient to protect against dietary obesity
(Howard et al., 2004; Kievit et al., 2006). In this study, we find
that the pathogenic induction of hypothalamic SOCS3 during
overnutrition also requires NF-kB. More important, suppression
of IKKb/NF-kB weakens the promotion of SOCS3 expression by
various in vitro and in vivo conditions known to desensitize
insulin and leptin signaling. While other mechanisms remain to
be explored, SOCS3 is an essential mediator for the pathological
actions of hypothalamic IKKb/NF-kB in causing central leptin
and insulin resistance that underlie obesity and T2D.
Hypothalamic IKKb as a Potential Target to Counter
Obesity and T2D
Our work also marks an initial attempt to study whether inhibiting
an innate immune pathway in the hypothalamus could help to
calibrate the set point of nutritional balance and therefore aid
in counteracting energy imbalance and diseases induced by
overnutrition. These results reveal that dietary obesity can be
largely prevented by inhibiting IKKb/NF-kB either virally or genet-
ically, whether broadly throughout the CNS, locally in the related
hypothalamic regions, or precisely in a defined subpopulation of
hypothalamic neurons. Altogether, our results suggest a novel
therapeutic strategy for combating the ever-increasing spread
of obesity and associated diseases. We recognize that the signif-
icance of this strategy has yet to be realized in clinical practice;
currently, most anti-inflammatory therapies have limited direct
effects on IKKb/NF-kB and limited capacity to be concentrated
in the CNS. Nonetheless, our discoveries offer potential for treat-
ing these serious diseases. Because we also revealed that IKKb/
NF-kB normally remains inactive in the CNS, suppressing IKKb/
NF-kB in the hypothalamus is likely a safe approach. However,
challenges still remain, such as finding methods to selectively
suppress this pathway in the CNS, that will certainly inspire fu-
ture research.
EXPERIMENTAL PROCEDURES
Animal Models and Chemicals
NGL mice (Everhart et al., 2006), IKKblox/lox mice (Arkan et al., 2005), and
AGRP-Cre mice (Xu et al., 2005) have been described previously. Nestin-Cre
mice, ob+/+ mice, db+/+ mice, and C57BL/6 mice were obtained from Jackson
Laboratory. All the mouse lines were in C57BL/6, except for AGRP-Cre mice,
which were originally in the FVB background. We backcrossed AGRP-Cre
mice to C57BL/6 background for five generations. We identified and excluded
a small fraction of whole-body IKKb knockout offspring from breeding AGRP-
Cre mice with IKKblox/lox mice. These mice were identified by using a PCR
method to detect the excised IKKb gene in the genomes isolated from various
peripheral and brain tissues. The UW-Madison IACUC approved the proce-
dures. The HFD and normal chow were from Research Diets, Inc. and Harlan
Teklad. TUDCA and TM were from Calbiochem, insulin was from Novartis, and
leptin from R & D Systems.
Third-Ventricle and Intrahypothalamic Injections
The bilateral injections to the MBH were directed using an ultra-precise stereo-
tax (Kopf Instruments) to the coordinates of 1.5 mm posterior to the bregma,
5.8 mm below the surface of the skull, and 0.4 mm lateral to midline. Purified
lentivirus or adenovirus in artificial cerebrospinal fluid (aCSF) was injected
over 10 min through a 26-gauge guide cannula and a 33-gauge injector con-
nected to a Hamilton Syringe and an infusion pump. At the end of the experi-
ments, the mice were assessed for intra-MBH deliveries by immunostaining
the markers and the targets. Our final analyses included only those animals
in which target induction was limited to the MBH and in which more than
70% of the targeted MBH cells were infected (Figures S1B and S1C). For
third-ventricle cannulation, we implanted a guide cannula into the ventral third
ventricle at the midline coordinates of 1.8 mm posterior to the bregma and
5.0 mm below the surface of the skull.Acute Food Intake Studies and GTT
The individually housed mice were first measured for food intake induced by
fasting. Four hours before the designated ‘‘night time,’’ we removed food
and injected 1–2 ml of the vehicle (aCSF) into the third ventricle of each mouse.
Food was then returned to the mice immediately before the designated
‘‘night time.’’ Food intake for each mouse was measured during the various
following periods. This procedure was subsequently performed for the same
set of mice but using instead an injection of insulin (5–10 mU) or leptin (5–
15 mg). For GTT, overnight-fasted mice were IP injected with glucose (2 g/kg
body weight). Blood glucose at various time points was measured using
a Glucometer Elite (Bayer).
Plasmids and Recombinant Viruses
We introduced the cDNA of IKKbCA (S177/181E), IKKbDN (either S177/181A or
K44A), or SOCS3 (provided by J. Seufert) into the lentiviral vector Lox-Syn-Syn
(provided by G. Francisco) in which the synapsin promoter controlled neuron-
specific expression of the introduced genes. The lentiviruses were produced
from HEK293T cells through cotransfecting the target plasmid with package
plasmids using CaCl2. Lentiviruses were purified by ultracentrifugation and
then quantitated. Ad5-CMV-driven Cre adenovirus was provided by S. Albelda.
Ad5-CMV-driven IKKb adenovirus and Ad5-CMV-driven GFP or LacZ were
produced in our lab or in a core facility at UW-Madison.
Tissue Harvest, Immunoprecipitation, and Western Blots
The hypothalamus was dissected according to the established method (Kim
et al., 2006) (Figure S1A). Animal tissues were homogenized, and the proteins
were dissolved in a lysis buffer, and western blots were performed as previ-
ously described (Cai et al., 2004, 2005). Proteins dissolved in a lysis buffer
or isolated by immunoprecipitation were separated by SDS-PAGE and identi-
fied by immunoblotting. Primary antibodies included rabbit anti-p-STAT3,
anti-STAT3, anti-p85, anti-p-Akt, anti-Akt, anti-IKKb, anti-IKKa, anti-eIF2a,
anti-p-eIF2a, anti-p-ERK, and anti-b-Actin (Cell Signaling); rabbit anti-IkBa,
anti-PERK, anti-GFP, and anti-tubulin (Santa Cruz). Secondary antibodies
included HRP-conjugated anti-rabbit and anti-mouse antibodies (Pierce).
Quantitative RT-PCR and EMSA
We extracted total RNA from homogenized tissues using TRIzol (Invitrogen),
synthesized cDNA using the Advantage RT for PCR kit (BD Biosciences),
and performed real-time PCR using SYBRGreen PCR Master Mix (Applied
Biosystems). Results were normalized against TATA box-binding protein (TBP)
or GAPDH gene expression. We performed EMSA using the protocol detailed
in our previous publications (Cai et al., 2004, 2005). Briefly, NF-kB oligonucle-
otide (Santa Cruz) and two control oligonucleotides, Sp1 and Oct1 (Promega),
were labeled with [g-32P] ATP. The animal tissues were homogenized in a lysis
buffer, and the lysate was then incubated with the probe. For negative con-
trols, we used both mutant NF-kB gel-shift oligonucleotide (Santa Cruz) and
cold competition with 200-fold excess of unlabeled NF-kB gel-shift oligonucle-
otide. The NF-kB-probe complex was separated in undenatured 4% PAGE,
and the radioactivity was then detected on X-ray film.
Heart Perfusion, Immunostaining, and In Situ Hybridization
Mice under anesthesia were transcardially perfused with 4% PFA, and the
brains were removed, post-fixed in 4% PFA, and infiltrated with 20%–30% su-
crose. Brain sections across the MBH (15 mm thickness) were blocked with se-
rum of appropriate species, penetrated with 0.2% Triton X-100, treated with
anti-Flag (Stratagene), anti-IKKb (Santa Cruz), anti-NeuN (Chemicon), anti-
GFAP (Dako), anti-pSTAT3 (Cell Signaling), anti-PIP3 (Echelon), anti-SOCS3
(IBL), or anti-AGRP (Phoenix Pharmaceutical Inc) antibodies, and then sub-
jected to reaction with fluorescence-conjugated secondary antibodies (Jack-
son). Naive IgGs of the appropriate species were used as negative controls.
For in situ hybridization, free-floating slices were digested with proteinase K,
prehybridized, and then hybridized with digoxigenin-labeled antisense IKKb
nucleotide probe, and followed by color development using anti-digoxigenin
antibody (Fab) conjugated with alkaline phosphatase (Roche) and NBT/BCIP
substrates.Cell 135, 61–73, October 3, 2008 ª2008 Elsevier Inc. 71
Statistical Analyses
Data are presented as mean ± SEM. Student’s t tests were used for statistical
analysis. p < 0.05 was considered significant.
SUPPLEMENTAL DATA
Supplemental Data include Supplemental Experimental Procedures, one ta-
ble, and sixteen figures and can be found with this article online at http://
www.cell.com/cgi/content/full/135/1/61/DC1/.
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